Volta Medical Inc
$643.0K 264 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Carlsmed, Inc.
Carlsmed, Inc. reported $643,499.01 across General Payments, Research, and Ownership to 1,199 physicians and teaching hospitals across 1,207 transactions.
- $643.5K Above-median payer
- All-tracks total
- 1,207 Above-median volume
- Transactions
- 1,199 Above-median reach
- Recipients
- +$81.3K
- General Payments vs PY2023
Carlsmed, Inc. reported $643,499.01 across all CMS Open Payments tracks (General + Research + Ownership) to 1,199 physicians and teaching hospitals in Program Year 2024 - ranking #711 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $436,947.01, averaging $536.70 per recipient.
How Carlsmed, Inc.'s $643.5K all-tracks total breaks down
Carlsmed, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
16/100
Transaction volume
F
19/100
Physician reach
F
19/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer carlsmed-inc Carlsmed, Inc.
$643.5K · #711/1,925 · 0.0% industry · PY2024
- TOT $643.5K
- RANK #711
- SHARE 0.0%
- TXN 1,207
- RCP 1,199
- CAT 3
- GEN $436.9K
- ΔGEN +$81.3K
- TOP1 11.0%
- PY 2024
Volume peers
Nearest volume peer: Volta Medical Inc ($643.0K)
Carlsmed, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Carlsmed, Inc.'s CMS-reported General Payments increased by $81.3K (+22.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CARLSMED, INC.PY2023: CARLSMED, INC.PY2024: Carlsmed, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $355,637.78
- PY2024
- $436,947.01
What the Data Shows for Carlsmed, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Carlsmed, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
47 transactions worth $272.9K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 62.5% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 3 types of general payments, Carlsmed, Inc.'s largest category was "Consulting Fee" at $272.9K - 62.5% of General Payments.
How Carlsmed, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $272.9K | 47 | 62.5% |
| Travel and Lodging | $100.9K | 199 | 23.1% |
| Food and Beverage | $63.2K | 953 | 14.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $164,181.61 (37.6%) of $436,947.01 in this company's General Payments records across 321 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Carlsmed, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Justin Smith
$47,901.31 across 23 reported transactions
- 2
Roland Kent
$34,303.08 across 23 reported transactions
- 3
Joseph Osorio
$28,794.54 across 18 reported transactions
- 4
John Small
$28,537.66 across 55 reported transactions
- 5
Chun Po Yen
$24,645.02 across 28 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Carlsmed, Inc. ranks #711 of 1,925 by total payments (top 37% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,315 of 1,838 by HHI (bottom 29% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Shoulder Innovations, Inc. : $2.2M total payments, HHI 471
- Sage Therapeutics, Inc. : $815.5K total payments, HHI 470
- IsoRay, Inc : $2.5K total payments, HHI 469
- International Rehabilitative Sciences, Inc : $502.5K total payments, HHI 469
- ZOLL Circulation Inc : $600.9K total payments, HHI 468
- H. Lundbeck A S : $804.7K total payments, HHI 465
- Carlsmed, Inc. (this company) : $436.9K total payments, HHI 464
- Cascination AG : $694.27 total payments, HHI 464
- Kite Pharma, Inc. : $1.3M total payments, HHI 462
- Musculoskeletal Transplant Foundation Inc. : $1.7M total payments, HHI 461
- MED-EL Corporation : $1.1M total payments, HHI 459
- Fusion Orthopedics USA, LLC : $655.1K total payments, HHI 458
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Carlsmed, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Carlsmed, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Carlsmed, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Canon Medical Systems USA, Inc.
$640.6K 560 recipients
Compare payment profiles
Edap Technomed Inc
$640.3K 2,475 recipients
Compare payment profiles
Wilson Cook Medical Incorporated
$646.8K 196 recipients
Compare payment profiles
Novo Nordisk Health Care AG
$647.6K 208 recipients
Compare payment profiles
Seigla Medical, Inc.
$651.1K 12 recipients
Compare payment profiles
Put this to use
Carlsmed, Inc. ranks #711 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Carlsmed, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.